Edgewise Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Edgewise Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q3 2024.
  • Edgewise Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 94.7M shares, a 49.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 94.7M +31.2M +49.2% Oct 31, 2024 10-Q 2024-11-07
Q2 2024 93.8M +30.3M +47.8% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 93.4M +30.1M +47.6% Apr 30, 2024 10-Q 2024-05-09
Q4 2023 93.1M +29.8M +47.2% Jan 31, 2024 10-K 2024-02-22
Q3 2023 63.5M +248K +0.39% Oct 31, 2023 10-Q 2023-11-09
Q2 2023 63.5M +13.7M +27.4% Jul 31, 2023 10-Q 2023-08-10
Q1 2023 63.3M +13.7M +27.6% Apr 30, 2023 10-Q 2023-05-11
Q4 2022 63.3M +13.8M +27.8% Jan 31, 2023 10-K 2023-02-23
Q3 2022 63.2M +13.9M +28.2% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 49.8M +538K +1.09% Jul 31, 2022 10-Q 2022-08-04
Q1 2022 49.6M +321K +0.65% Apr 30, 2022 10-Q 2022-05-11
Q4 2021 49.5M Jan 31, 2022 10-K 2022-02-24
Q3 2021 49.3M Oct 31, 2021 10-Q 2021-11-10
Q2 2021 49.3M Jul 30, 2021 10-Q 2021-08-09
Q1 2021 49.3M Apr 30, 2021 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.